DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Aortic stenosis.

TAVR 111

TAVR Stenosis Aortic Aortic valve 111

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

AMS Cardiology

APRIL 16, 2024

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. If you’re wondering “ What is TAVR ?” Understanding Aortic Stenosis The aortic valve regulates blood flow from your heart’s main pumping chamber to the rest of your body. Who Is a Candidate for TAVR?

Aortic valve 40

Aortic valve TAVR Aortic Open-Heart Surgery 40